跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 雋曦
教授
藥理學科暨藥理學研究所
電話
886 6 2353535 ext 5483
電子郵件
acheung
mail.ncku.edu
tw
h-index
8499
引文
27
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
2009
2025
每年研究成果
概覽
指紋
網路
專案
(9)
研究成果
(62)
類似的個人檔案
(6)
監製作品
(10)
指紋
查看啟用 Chun Hei Antonio Cheung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Survivin
71%
Drug Resistance
40%
Neoplasm
21%
Aurora Kinase Inhibitor
21%
Cathepsin S
14%
Cell Viability
12%
Tubulin
11%
Aurora Kinase
11%
Breast Cancer
11%
Cytotoxicity
10%
Tamoxifen
10%
Antiproliferative Activity
10%
Multidrug Resistance Protein 1
10%
Antiapoptotic
9%
Recombinant Protein
9%
Learning Disorder
8%
Nanoparticle
8%
Sepantronium Bromide
8%
Locked Nucleic Acid
7%
X Linked Inhibitor of Apoptosis
7%
Cisplatin
7%
Adenosine Triphosphatase
7%
Chia
7%
Plasmid DNA
7%
Birinapant
7%
Reactive Oxygen Metabolite
7%
2,5-Dimethoxy-4-iodoamphetamine
7%
Microtubule Inhibitors
7%
Caspase 8
7%
DNA Methyltransferase
7%
Uvomorulin
7%
Fingolimod
7%
Hypoxia
7%
Methylated DNA Protein Cysteine Methyltransferase
7%
Low Molecular Weight Heparin
7%
microRNA
7%
Histone Deacetylase 3
7%
Memory Disorder
7%
Cancer Model
7%
Alzheimer's Disease
7%
N [1 Cyclohexyl 2 [2 [4 (4 Fluorobenzoyl) 2 Thiazolyl] 1 Pyrrolidinyl] 2 Oxoethyl] 2 (Methylamino)propanamide
7%
Escherichia coli
7%
Estrogen Receptor Positive Breast Cancer
7%
Agents Acting on the Eye
7%
Clinical Feature
7%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
7%
Vorinostat
7%
Xanthine Oxidase
7%
Beta Tubulin
7%
Keyphrases
Cancer Cells
14%
Smac Mimetics
14%
Alkali Burn
14%
Topical Ophthalmic
14%
SurR9-C84A
14%
Quick Recovery
14%
Corneal Haze
14%
Ophthalmic Formulation
14%
Drug Resistance
11%
GDC-0152
8%
BIRC5
7%
YM155
7%
Later Life
7%
Tyrosine
7%
Autophagy
7%
β-tubulin Isotypes
7%
Interferon-α (IFN-α)
7%
Apologizing
7%
Birinapant
7%
Signal Transduction
7%
Apoptotic Molecules
7%
In Cancer
7%
Small Molecule Inhibitors
7%
Human Error
7%
Toll-like
7%
Survivin Protein
7%
Cell Permeable
7%
Clinical Testing
7%
Microtubule Inhibitor
7%
Macrophages
7%
MicroRNA-125b
7%
Nanodrug
7%
Cancer Cell Resistance
7%
Non-homologous End Joining
7%
Selenophene
7%
Compound D
7%
Interaction Hotspot
7%
Caspase-8
7%
Hotspot Detection
7%
In Vitro Testing
7%
Structure-based Virtual Screening
7%
Luminal B
7%
PTCH1 Gene
7%
Preclinical Testing
7%
Anticancer Drugs
7%
Proliferative Effect
7%
Cell Autophagy
7%
FasL
7%
Phosphorylation
7%
MCF-7 Cancer Cells
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
38%
Autophagy
28%
Drug Resistance
19%
Genome Instability
14%
Hypoxia Inducible Factor 1
11%
Downregulation
9%
Radiosensitivity
9%
Proteasome
9%
Histone Deacetylase 5
9%
Survivin
8%
Cell Viability
8%
Tubulin
7%
Cytotoxicity
7%
Estrogen Receptor
7%
Hsp90
7%
HDAC3
7%
ATPase
7%
PTCH1
7%
Cathepsin S
7%
Ubiquitin
7%
DNA Repair
7%
Protein Kinase B
7%
Clonogenesis
7%
BRCA Gene
7%
HDAC6
7%
Hypoxia-Inducible Factors
7%
Cytotoxic Concentration
5%